glp 1 agonist structure GLP-1 Receptor Agonists Human GLP-1 receptor transmembrane domain

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Learn how GLP-1 drugs can help you lose weight, which ones are best, and where to get them.

Learn what patients and prescribers should know about lean mass, protein, and exercise.

Is berberine a GLP-1 agonist

Patients have found compounded semaglutide to be a cheaper, accessible GLP-1, but health experts warn of risks tied to the non-FDA-approved drugs.